Johnson Matthey CFO Anna Manz to step down and join London Stock Exchange Group

Pharma

Johnson Matthey plc (LON:JMAT) has announced that Anna Manz, Chief Financial Officer, has decided to leave the group after almost four years and will join London Stock Exchange Group as Chief Financial Officer and a member of the board of LSEG plc. 

Anna will leave JM and step down from our board on 20th November 2020, the day after the publication of the company’s interim results. 

A process has commenced to identify a successor to Anna and an appointment will be announced in due course.

Robert MacLeod, Chief Executive of JM said: “Anna has made a significant contribution to JM since she joined us back in 2016.  Her absolute focus on efficiency and strategy execution has already delivered tangible benefits and she has played an important role in creating the strong foundations to drive efficiency and growth in JM for many years to come.  Most recently, her leadership during the COVID-19 pandemic helped secure the company’s financial strength in unprecedented times. 

Anna has shown great passion for our purpose to use our science to create a cleaner, healthier world and she leaves a strong team and capable finance function. 

On behalf of Johnson Matthey, I’d like to thank Anna and wish her every success for the future.”

Share on:

Latest Company News

Johnson Matthey issues pre-close update and reclassifies Catalyst Technologies

Johnson Matthey has confirmed that Catalyst Technologies, following its agreed sale to Honeywell, will be reported as a discontinued operation for 2025/26. In its pre-close update for the half year to 30 September 2025, the group expects strong growth in underlying operating profit, supported by efficiency gains and robust trading in PGM Services.

Johnson Matthey appoints Richard Pike as Chief Financial Officer Designate

Johnson Matthey plc appoints Richard Pike as Chief Financial Officer Designate, effective immediately, ensuring a smooth transition before April 2025.

Johnson Matthey Plc hosting PGM Services seminar for investors and analysts today

Join Johnson Matthey plc (LON:JMAT) as they host a PGM Services seminar, revealing how PGM Services drive the net zero transition and unlock growth opportunities.

Johnson Matthey Plc to sell Medical Device Components business for $700 million

Johnson Matthey Plc (LON:JMAT) has signed an agreement to sell its Medical Device Components business to Montagu Private Equity for US$700 million (£550 million).

    Search

    Search